Literature DB >> 3289653

Iron status and cellular immune competence.

M F Good1, L W Powell, J W Halliday.   

Abstract

There is increasing evidence that both iron overload and iron deficiency are associated with significant abnormalities of immune function. In diseases associated with iron overload there is increased susceptibility to both infection and neoplasia. The precise mechanisms are still being unravelled but iron overload has been shown to impair antigen-specific immune responses and to reduce the number of functional helper precursor cells. Similarly, iron in vitro in concentrations reported to be present in the serum of patients with iron overload impairs the generation of cytotoxic T-cells, enhances suppressor T-cell activity and reduces the proliferative capacity of helper T-cells. The predominant tumor seen in iron overload is primary hepatocellular carcinoma; however other aetiological factors appear to be involved in addition to iron overload, especially hepatic cirrhosis. Nevertheless, primary liver cancer occurs much more frequently in hemochromatosis than in other forms of cirrhosis. Iron deficiency is associated with an altered response to infection but the relationship is again a complex one. The cellular mechanisms involved have yet to be clearly defined, although impaired T and B cell function have been demonstrated.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3289653     DOI: 10.1016/0268-960x(88)90007-0

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  6 in total

Review 1.  Immune cell functions in iron overload.

Authors:  M de Sousa
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

Review 2.  Immunological effects of iron oxide nanoparticles and iron-based complex drug formulations: Therapeutic benefits, toxicity, mechanistic insights, and translational considerations.

Authors:  Ankit Shah; Marina A Dobrovolskaia
Journal:  Nanomedicine       Date:  2018-02-02       Impact factor: 5.307

3.  Hepatic iron contents and response to interferon-alpha in patients with chronic hepatitis C. Relationship to genotypes of hepatitis C virus.

Authors:  N Izumi; N Enomoto; M Uchihara; T Murakami; K Ono; O Noguchi; S Miyake; T Nouchi; K Fujisawa; F Marumo; C Sato
Journal:  Dig Dis Sci       Date:  1996-05       Impact factor: 3.199

Review 4.  Serum ferritin: Past, present and future.

Authors:  Wei Wang; Mary Ann Knovich; Lan G Coffman; Frank M Torti; Suzy V Torti
Journal:  Biochim Biophys Acta       Date:  2010-03-19

5.  Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events.

Authors:  Weihong Zhang; Yuan Meng; Lin Yang; Meng Shen; Li Zhou; Runmei Li; Yang Wang; Weijiao Du; Yanjuan Xiong; Ying Han; Xinwei Zhang; Liang Liu; Xiubao Ren
Journal:  Cancer Biol Med       Date:  2021-08-11       Impact factor: 4.248

6.  Higher N stage and serum ferritin, but lower serum albumin levels are associated with distant metastasis and poor survival in patients with nasopharyngeal carcinoma following intensity-modulated radiotherapy.

Authors:  Xiaoqian Chen; Xianfeng Long; Zhongguo Liang; Hao Lei; Ling Li; Song Qu; Xiaodong Zhu
Journal:  Oncotarget       Date:  2017-04-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.